Terminal Sterilization Influences the Efficacy of an Extracellular Matrix-Blood Composite for Treating Post-Traumatic Osteoarthritis in the Rat Model

The objective was to determine if an intraarticular injection of an extracellular matrix (ECM) powder and blood composite (ECM-B) after anterior cruciate ligament (ACL) injury would have a mitigating effect on post-traumatic osteoarthritis, and if that effect would be different with terminal sterili...

Full description

Saved in:
Bibliographic Details
Published inJournal of orthopaedic research Vol. 40; no. 3; pp. 573 - 583
Main Authors Karamchedu, Naga Padmini, Fleming, Braden C., Proffen, Benedikt L., Sant, Nicholas J., Portilla, Gabriela, Parola, Lauren R., Molino, Janine, Murray, Martha M.
Format Journal Article
LanguageEnglish
Published 05.05.2021
Online AccessGet full text

Cover

Loading…
More Information
Summary:The objective was to determine if an intraarticular injection of an extracellular matrix (ECM) powder and blood composite (ECM-B) after anterior cruciate ligament (ACL) injury would have a mitigating effect on post-traumatic osteoarthritis, and if that effect would be different with terminal sterilization of the ECM powder prior to use. Eighty Lewis rats underwent ACL transection and were divided into four groups: 1) intraarticular injection with PBS (PBS; n = 20), 2) intraarticular injection of ECM-B using aseptically processed ECM (ASEPTIC; n = 20), 3) intraarticular injection of the ECM-B using ECM powder sterilized with 15 kGy electron beam irradiation (EBEAM; n=20), and 4) intraarticular injection of the ECM-B using ECM powder sterilized with ethylene oxide (EO; n=20). Twenty additional animals received capsulotomy only (SHAM). Animals were followed for 6 weeks and evaluations of gait, radiographs and joint cartilage histology were performed. At 6 weeks, when compared to the SHAM group, the group treated with PBS had significantly worse gait and histologic changes, while the ASEPTIC group was not different from SHAM for either of these outcomes. When compared to the SHAM group, the EO group had similar gait outcomes, but greater histologic damage, and the EBEAM group had significantly worse gait and histological outcomes. The ECM-B composite produced using aseptically processed ECM powder mitigated the gait and histologic changes associated with osteoarthritis after ACL transection in the rat; however, care must be taken when selecting a terminal sterilization method as this may affect the effectiveness of treatment.
Bibliography:All authors have made substantial contributions to the study design, acquisition, analyses or interpretation of the data, have contributed to drafting of the manuscript, and have read and approved the final submitted version.
ISSN:0736-0266
1554-527X
DOI:10.1002/jor.25056